Conformis, Inc. to Participate in Upcoming Investor Conferences
Conformis, a medical device company specializing in personalized orthopedic solutions, announced participation in two virtual investor conferences in September 2021. The first is the H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15, where on-demand presentations will be available. The second is the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 20-23, featuring a presentation by management on September 21 at 1:15 p.m. ET. Both events will offer opportunities for one-on-one meetings with management.
- None.
- None.
BILLERICA, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features a range of personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will participate in two virtual investor conferences in September 2021.
H.C. Wainwright 23rd Annual Global Investment Conference
- The H.C. Wainwright 23rd Annual Global Investment Conference will take place September 13-15, 2021. A virtual presentation will be available to watch on-demand and a webcast of the presentation will be available at https://journey.ct.events/view/906c3fe3-3008-421a-970a-bb8933d0dfb5.
- Conformis management will also be available for one-on-one meetings throughout the conference. For more information about the conference or to schedule a one-on-one meeting with management, please contact your H.C Wainwright representative or contact Investor Relations at ir@conformis.com or (781) 374-5598.
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
- The Oppenheimer Fall Healthcare Life Sciences & MedTech Summit will take place virtually September 20-23, 2021. Conformis management will present on September 21, 2021 at 1:15 p.m. ET. A live webcast of the presentation will be available at https://wsw.com/webcast/oppenheimer16/cfms/2767483.
- Conformis management will also be available for one-on-one meetings throughout the conference. For more information about the conference or to schedule a one-on-one meeting with management, please contact your Oppenheimer representative or contact Investor Relations at ir@conformis.com or (781) 374-5598.
About Conformis, Inc.
Conformis is a medical technology company that uses its proprietary iFit® Image-to-Implant® technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, which we refer to as personalized, individualized, or sometimes as customized, to fit and conform to each patient’s unique anatomy. Conformis also offers Identity Imprint™, a new line of total knee replacement products that utilizes a proprietary algorithm to select the implant size that most closely meets the geometric and anatomic requirements of the patient’s knee. Conformis’ sterile, just-in-time, Surgery-in-Box™ delivery system is available with all of its implants and personalized, single-use instruments. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.
For more information, visit www.conformis.com. To receive future releases in e-mail alerts, sign up at ir.conformis.com.
FAQ
What are the details of Conformis' participation in the H.C. Wainwright 23rd Annual Global Investment Conference?
When will Conformis present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit?
How can investors schedule one-on-one meetings with Conformis management during the conferences?
What technology does Conformis utilize for personalized orthopedic solutions?
Where can I find more information about Conformis and its products?
